Acadian Asset Management LLC Fulgent Genetics, Inc. Transaction History

Acadian Asset Management LLC

$35.4 Billion
Q1 2025

A detailed history of Acadian Asset Management LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 805,941 shares of FLGT stock, worth $16.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

805,941

Previous 359,865 123.96%

Holding current value

$16.3 Million

Previous $6.64 Million 104.95%

% of portfolio

0.04%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 21, 2025	BUY	$15.28 - $18.95 $6.82 Million - $8.45 Million	446,076 Added 123.96%	805,941 $13.6 Million
Q4 2024 Feb 11, 2025	BUY	$16.71 - $22.68 $990,685 - $1.34 Million	59,287 Added 19.72%	359,865 $6.64 Million
Q3 2024 Nov 12, 2024	BUY	$19.6 - $25.06 $4.66 Million - $5.96 Million	237,854 Added 379.21%	300,578 $6.53 Million
Q2 2024 Aug 06, 2024	BUY	$19.09 - $22.57 $1.02 Million - $1.21 Million	53,680 Added 593.54%	62,724 $1.23 Million
Q1 2024 May 10, 2024	BUY	$21.55 - $29.29 $194,898 - $264,898	9,044 New	9,044 $195,000
Q4 2022 Feb 14, 2023	SELL	$29.23 - $40.28 $322,582 - $444,530	-11,036 Reduced 52.97%	9,799 $291,000
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $321,372 - $540,196	8,475 Added 68.57%	20,835 $793,000
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $321,372 - $540,196	8,475 Added 68.57%	20,835 $793,000
Q2 2022 Aug 09, 2022	SELL	$47.98 - $62.75 $142,164 - $185,928	-2,963 Reduced 19.34%	12,360 $675,000
Q4 2021 Feb 10, 2022	SELL	$77.3 - $105.0 $240,248 - $326,340	-3,108 Reduced 16.86%	15,323 $1.54 Million
Q3 2021 Nov 12, 2021	SELL	$74.87 - $110.87 $1.55 Million - $2.3 Million	-20,755 Reduced 52.97%	18,431 $1.66 Million
Q2 2021 Aug 11, 2021	BUY	$66.8 - $100.45 $2.62 Million - $3.94 Million	39,186 New	39,186 $3.61 Million
Q3 2020 Nov 09, 2020	SELL	$15.89 - $50.51 $2.35 Million - $7.46 Million	-147,717 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$8.89 - $18.28 $625,758 - $1.29 Million	-70,389 Reduced 32.27%	147,717 $2.36 Million
Q1 2020 May 11, 2020	BUY	$6.75 - $19.75 $588,721 - $1.72 Million	87,218 Added 66.64%	218,106 $2.35 Million
Q4 2019 Feb 06, 2020	BUY	$9.29 - $15.82 $1.02 Million - $1.74 Million	110,207 Added 532.89%	130,888 $1.69 Million
Q3 2019 Nov 07, 2019	BUY	$5.96 - $12.81 $123,258 - $264,923	20,681 New	20,681 $214,000

Others Institutions Holding FLGT

# of Institutions

197

Shares Held

18.2M

Call Options Held

379K

Put Options Held

52.9K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $611M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Fulgent Genetics, Inc. Transaction History